MedVellum
MedVellum
Back to Library

Rhabdomyolysis

On This Page

Overview

Rhabdomyolysis

Quick Reference

Critical Alerts

  • AKI occurs in 15-50%: Aggressive IV fluids are key to prevention
  • Hyperkalemia can be fatal: Monitor potassium closely; treat aggressively
  • CK >5000 is high risk for AKI: Threshold for aggressive hydration
  • Compartment syndrome may coexist: Check compartments in trauma
  • Target urine output 200-300 mL/hr: High-volume fluid resuscitation
  • Avoid nephrotoxins: NSAIDs, contrast, aminoglycosides

Key Diagnostics

TestFindingSignificance
CK (Creatine Kinase)>1000 U/L (often >0,000)Defines rhabdomyolysis
PotassiumElevatedLife-threatening arrhythmia risk
CreatinineElevatedIndicates AKI
UrinalysisPositive blood, no RBCsMyoglobinuria
CalciumLow (early) or high (late)Calcium sequestration then release
PhosphateElevatedReleased from muscle cells

Emergency Treatments

InterventionDetailsGoal
IV fluidsNS or LR 1-2 L/hr initiallyUO 200-300 mL/hr
HyperkalemiaCalcium gluconate, insulin/glucose, albuterolCardioprotection + shift
Metabolic acidosisBicarbonate (controversial)pH >.2
DialysisIf refractory hyperkalemia or severe AKIRRT

Definition

Overview

Rhabdomyolysis is the breakdown of skeletal muscle fibers with release of intracellular contents (myoglobin, creatine kinase, potassium, phosphate) into the bloodstream. It ranges from asymptomatic CK elevation to life-threatening acute kidney injury (AKI) and fatal hyperkalemia.

Classification

By Severity:

CategoryCK LevelRisk
Mild<5,000 U/LLow AKI risk
Moderate5,000-15,000 U/LModerate AKI risk
Severe>5,000 U/LHigh AKI risk
Massive>00,000 U/LVery high risk

By Cause:

TypeExamples
TraumaticCrush injury, compartment syndrome, surgery
ExertionalExercise, seizures, heat stroke
Non-traumatic/non-exertionalDrugs, infections, metabolic

Epidemiology

  • Incidence: 26,000+ hospitalizations/year in US
  • AKI incidence: 15-50% of rhabdomyolysis patients
  • Mortality: 5% overall; higher with AKI and dialysis
  • Most common causes: Trauma (30%), drugs/toxins (30%), immobilization (15%)

Etiology

Common Causes:

CategoryCauses
Trauma/CompressionCrush injury, prolonged immobility, coma, restraints
ExertionalIntense exercise, marathon, military training, seizures
Drugs/ToxinsStatins, cocaine, amphetamines, alcohol, heroin
InfectionsViral (influenza, COVID), bacterial (Legionella, Strep)
MetabolicHypokalemia, hypophosphatemia, DKA, hypothyroidism
HyperthermiaHeat stroke, malignant hyperthermia, NMS
IschemiaCompartment syndrome, arterial occlusion
InflammatoryDermatomyositis, polymyositis
GeneticMcArdle disease, malignant hyperthermia susceptibility

Drug-Induced Rhabdomyolysis:

CategoryAgents
StatinsEspecially with fibrates or CYP3A4 inhibitors
Illicit drugsCocaine, amphetamines, MDMA, heroin
AlcoholBinge drinking, immobility
AntipsychoticsNMS
SedativesImmobilization
ColchicineToxicity
PropofolPropofol infusion syndrome

Pathophysiology

Mechanism of Muscle Injury

  1. ATP depletion: Ischemia, exertion, or drugs → decreased ATP
  2. Pump failure: Na+/K+-ATPase and Ca2+-ATPase fail
  3. Intracellular calcium rises: Activates proteases and lipases
  4. Myocyte necrosis: Cell membrane ruptures
  5. Contents released: CK, myoglobin, K+, phosphate, uric acid

Mechanism of Acute Kidney Injury

MechanismPathophysiology
Renal vasoconstrictionMyoglobin scavenges NO
Tubular obstructionMyoglobin precipitates in acidic urine
Direct tubular toxicityFree iron from myoglobin generates ROS
HypovolemiaThird-spacing into injured muscle

Factors Increasing AKI Risk:

  • Volume depletion
  • Acidic urine (pH <5.6)
  • CK >15,000 U/L
  • Pre-existing renal impairment
  • Sepsis
  • DIC

Electrolyte Disturbances

ElectrolyteEarly PhaseMechanism
Potassium↑ HyperkalemiaRelease from cells
Phosphate↑ HyperphosphatemiaRelease from cells
Calcium↓ HypocalcemiaCalcium deposits in damaged muscle
Uric acid↑ HyperuricemiaPurine breakdown

Late Phase:

  • Hypercalcemia (as calcium remobilizes from muscle)

Clinical Presentation

Classic Triad (Present in <10%)

  1. Myalgia: Muscle pain and tenderness
  2. Weakness: Affected muscle groups
  3. Dark urine: "Cola-colored" or "tea-colored" (myoglobinuria)

Symptoms

Musculoskeletal:

Systemic:

Urinary:

History

Key Questions:

Physical Examination

Vital Signs:

Musculoskeletal:

FindingSignificance
Muscle tendernessAffected muscle groups
Muscle swellingEdema, possible compartment syndrome
FirmnessCompartment syndrome
WeaknessMay be profound

Compartment Syndrome Assessment:

Other:


Muscle pain (50% of cases)
Common presentation.
Muscle weakness
Common presentation.
Muscle swelling
Common presentation.
Tenderness to palpation
Common presentation.
Red Flags

Life-Threatening Complications

FindingConcernAction
K+ >.5 mEq/L or ECG changesCardiac arrhythmia riskCalcium, insulin/glucose, dialysis
Oliguria/anuriaAcute kidney injuryAggressive fluids, nephrology
Metabolic acidosis (pH <7.2)Severe rhabdomyolysisBicarbonate, dialysis
Compartment syndromeLimb-threateningEmergent fasciotomy
CK >00,000 U/LVery high AKI riskICU, aggressive management
DICMulti-organ failureSupportive care
Cardiac arrest (from hyperkalemia)FatalACLS, dialysis

High-Risk Features

  • CK >15,000 U/L
  • Pre-existing CKD
  • Diabetes
  • Sepsis
  • Delayed presentation
  • Initial creatinine elevation

Differential Diagnosis

Other Causes of Elevated CK

DiagnosisFeatures
Acute MIChest pain, ECG changes, troponin > CK elevation
MyocarditisChest pain, ECG changes, cardiac biomarkers
Myositis (inflammatory)Chronic, proximal weakness, dermatomyositis rash
HypothyroidismFatigue, modest CK elevation, TFTs abnormal
Muscular dystrophyChronic, family history, characteristic pattern
Statin myopathy (without rhabdo)Myalgias, mild CK elevation

Other Causes of Dark Urine

DiagnosisFeatures
HemoglobinuriaHemolysis, positive hemolysis markers
HematuriaRBCs on microscopy
PorphyriaNeuropsychiatric symptoms, abdominal pain
Bile pigmentsElevated bilirubin, liver disease

Diagnostic Approach

Laboratory Studies

TestPurposeExpected Findings
CK (Creatine Kinase)Diagnostic>5× ULN (often >0,000)
BMPRenal function, K+Elevated Cr, K+, phosphate; low Ca2+
UrinalysisMyoglobinuriaBlood positive, no RBCs on microscopy
MyoglobinConfirmationElevated (less practical than CK)
CBCAssess for sepsis, DICWBC elevated, low platelets if DIC
CoagulationDIC screenPT/PTT elevated if DIC
Liver enzymesBaselineMay be mildly elevated
LactatePerfusionElevated if severe
ABG/VBGAcidosisMetabolic acidosis
Uric acidTumor lysis, rhabdoElevated

Urinalysis Interpretation

ParameterFinding
Blood (dipstick)Positive
RBCs (microscopy)Absent or few
ColorDark brown ("cola")

Positive blood without RBCs = Myoglobinuria (or hemoglobinuria)

ECG

  • Monitor for hyperkalemia changes:
    • Peaked T waves
    • Prolonged PR
    • Wide QRS
    • Sine wave (pre-arrest)

Imaging

  • CK/labs confirm diagnosis
  • Imaging for underlying cause or complications:
    • CT/MRI: Muscle necrosis, abscess
    • Compartment pressure: If clinical concern
    • Venous Doppler: DVT (from immobility)

Treatment

Principles of Management

  1. Aggressive IV fluids: Prevent AKI (most important)
  2. Treat hyperkalemia: Life-threatening
  3. Monitor and correct electrolytes: Calcium, phosphate
  4. Treat underlying cause: Stop offending drug, treat infection
  5. Avoid nephrotoxins: NSAIDs, contrast, aminoglycosides
  6. Dialysis if refractory: Severe AKI or hyperkalemia

IV Fluid Resuscitation

Target: Urine output 200-300 mL/hr (3 mL/kg/hr)

PhaseFluidRate
Initial resuscitationNS or LR1-2 L/hr first few hours
MaintenanceNS or LRTitrate to goal UOP
When stabilizedTaper as CK fallsContinue until CK <5000 and stable

Choice of Fluid:

  • Normal saline: Most commonly used
  • Lactated Ringer's: Contains small potassium; some avoid in hyperkalemia
  • Bicarbonate: Controversial; may alkalize urine but not proven beneficial

Urine Alkalization (Controversial):

  • Theoretical benefit: Myoglobin less toxic at pH >6.5
  • Regimen: Add bicarbonate to IV fluids
  • Evidence: Limited; may worsen hypocalcemia
  • NOT routinely recommended by current guidelines

Hyperkalemia Management

InterventionDoseMechanism
Calcium gluconate10 mL of 10% IVCardioprotection (no K+ decrease)
Insulin + Glucose10 units regular + 25g D50Shift K+ intracellularly
Albuterol10-20 mg nebulizedShift K+ intracellularly
Sodium bicarbonate50-100 mEq IVShift K+ (if acidotic)
Kayexalate15-30g PO or enemaElimination (slow)
DialysisIf refractory or severeDefinitive elimination

Electrolyte Management

Hypocalcemia:

  • Treat only if symptomatic (tetany, seizures, arrhythmia)
  • Aggressive calcium replacement may worsen deposition
  • Calcium rebinds calcium deposited in muscle during recovery

Hyperphosphatemia:

  • Usually resolves with fluids
  • Phosphate binders if severe

Acidosis:

  • Bicarbonate if pH <7.1-7.2
  • Usually improves with fluids

Dialysis Indications

Indication
Refractory hyperkalemia
Refractory metabolic acidosis
Severe oliguria/anuria
Volume overload
Uremic symptoms

Compartment Syndrome

  • Emergent surgical fasciotomy
  • Do not wait for CK or other labs
  • Clinical diagnosis

Specific Therapies for Underlying Cause

CauseTreatment
StatinsDiscontinue; avoid reintroduction
Illicit drugsSupportive care, benzodiazepines for agitation
NMSStop antipsychotic, dantrolene, cooling
Malignant hyperthermiaDantrolene, cooling, supportive
Heat strokeAggressive cooling, fluids
SeizuresTerminate seizure
InfectionAppropriate antibiotics/antivirals

Disposition

ICU Admission Criteria

  • CK >15,000-20,000 U/L
  • Acute kidney injury
  • Significant hyperkalemia
  • Hemodynamic instability
  • Need for dialysis
  • Underlying critical illness

Floor Admission

  • Moderate CK elevation (5,000-15,000)
  • Stable renal function
  • No significant electrolyte derangement

Discharge Criteria

  • CK trending down
  • Creatinine stable or improving
  • Adequate oral intake
  • No electrolyte abnormalities
  • Cause addressed

Follow-Up

SituationFollow-Up
Mild/resolvingPCP in 1-2 weeks; repeat CK and renal function
Post-AKINephrology follow-up
Recurrent episodesConsider genetic evaluation for metabolic myopathies
Statin-relatedCardiology for alternative lipid management

Patient Education

Condition Explanation

  • "Your muscle cells have broken down, releasing their contents into your blood."
  • "This can affect your kidneys and cause dangerous changes in your blood salt levels."
  • "We need to give you a lot of fluids to flush your kidneys and keep them working."

Prevention

  • Gradual increase in exercise intensity
  • Adequate hydration during exercise
  • Avoid extreme exertion in heat
  • Know signs of overexertion

Medication Awareness

  • Report muscle pain on statins immediately
  • Avoid combining statins with certain medications

Warning Signs for Return

  • Return of muscle pain or weakness
  • Dark urine
  • Decreased urine output
  • Swelling of limbs
  • Palpitations or lightheadedness

Special Populations

Exertional Rhabdomyolysis

  • More common in unconditioned individuals
  • Seen with novel exercise ("weekend warriors")
  • NSAID use increases AKI risk
  • Prevention: Gradual training, hydration

Statin-Induced

  • Risk factors: High-dose, CYP3A4 inhibitors, hypothyroidism
  • Discontinue statin; usually resolves
  • Rechallenge with different statin after resolution (with caution)

Crush Injury / Earthquake Victims

  • "Crush syndrome": Massive rhabdomyolysis + AKI + hyperkalemia
  • Start fluids before extrication if possible
  • Prepare for dialysis
  • Consider tourniquet to prevent reperfusion flush

Pediatric

  • Viral myositis is common cause
  • Genetic metabolic myopathies
  • Generally good prognosis

Elderly

  • Prolonged immobility is common cause
  • Higher AKI risk
  • More comorbidities

Quality Metrics

Performance Indicators

MetricTargetRationale
IV fluids initiated within 1 hour100%Prevents AKI
Potassium monitored q4-6h100%Detect hyperkalemia
Urine output documented100%Guide fluid therapy
Nephrotoxins avoided100%Prevent additional injury
CK trending100%Monitor response
Nephrology consult for AKI100%Specialty input

Documentation Requirements

  • Suspected or confirmed cause
  • Initial CK and peak CK
  • Urine output and fluid administration
  • Potassium trend and treatment
  • Creatinine trend
  • Disposition plan

Key Clinical Pearls

Diagnostic Pearls

  • CK is very sensitive: Can be elevated before symptoms
  • Dipstick positive blood without RBCs = myoglobinuria: Classic finding
  • Check for compartment syndrome in trauma: Pain out of proportion
  • CK >5000 = high risk for AKI: Threshold for aggressive management
  • Ask about drugs and exercise: Most common modifiable causes
  • Serum myoglobin is less useful: Clears before CK

Treatment Pearls

  • Fluids are the mainstay: Target UO 200-300 mL/hr
  • Don't wait for AKI to start fluids: Prevention is key
  • Bicarbonate not routinely recommended: May worsen hypocalcemia
  • Don't give calcium for asymptomatic hypocalcemia: May deposit in muscle
  • Treat hyperkalemia aggressively: It can kill quickly
  • Stop offending drugs: Statins, cocaine, etc.

Disposition Pearls

  • ICU for CK >15,000-20,000 or AKI: Close monitoring needed
  • Monitor CK until trending down: May continue to rise for 1-3 days
  • Recurrent rhabdomyolysis: Consider metabolic myopathy workup
  • Statin rechallenge possible: With different agent, low dose, monitoring

References
  1. Bosch X, et al. Rhabdomyolysis and Acute Kidney Injury. N Engl J Med. 2009;361(1):62-72.
  2. Chavez LO, et al. Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice. Crit Care. 2016;20(1):135.
  3. Giannoglou GD, et al. The syndrome of rhabdomyolysis: Pathophysiology and diagnosis. Eur J Intern Med. 2007;18(2):90-100.
  4. Brown CV, et al. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma. 2004;56(6):1191-1196.
  5. Zimmerman JL, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-1065.
  6. Torres PA, et al. Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment. Ochsner J. 2015;15(1):58-69.
  7. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.
  8. UpToDate. Clinical features and diagnosis of rhabdomyolysis. 2024.

At a Glance

EvidenceStandard
Last UpdatedRecently

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines